AlphaMark Advisors’s AtriCure ATRC Stock Holding History

AlphaMark Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-35	Closed	-$1K	–	714
2023 Q4	$1K	Hold	35	–	–	﹤0.01%	675
2023 Q3	$2K	Hold	35	–	–	﹤0.01%	649
2023 Q2	$2K	Hold	35	–	–	﹤0.01%	548
2023 Q1	$1K	Hold	35	–	–	﹤0.01%	573
2022 Q4	$2K	Hold	35	–	–	﹤0.01%	510
2022 Q3	$1K	Hold	35	–	–	﹤0.01%	621
2022 Q2	$1K	Buy	+35	New	+$1.66K	﹤0.01%	574
2018 Q2	–	Sell	-120	Closed	-$2K	–	519
2018 Q1	$2K	Hold	120	–	–	﹤0.01%	466
2017 Q4	$2K	Hold	120	–	–	﹤0.01%	466
2017 Q3	$3K	Hold	120	–	–	﹤0.01%	444
2017 Q2	$3K	Buy	+120	New	+$2.55K	﹤0.01%	456
2017 Q1	–	Sell	-120	Closed	-$2K	–	491
2016 Q4	$2K	Buy	+120	New	+$2.17K	﹤0.01%	429

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AlphaMark Advisors's ATRC Position: Q1 2024 in Review

AlphaMark Advisors sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 35 shares — an estimated $1K sold.

AlphaMark Advisors first reported a position in ATRC in Q4 2016 and held it in 12 quarters. The position peaked at $3K in Q3 2017. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.

AlphaMark Advisors reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
AlphaMark Advisors sold 35 AtriCure shares in Q1 2024, an estimated $1K.
AlphaMark Advisors first reported a position in AtriCure in Q4 2016 and held it in 12 quarters.
AlphaMark Advisors's AtriCure position peaked at $3K in Q3 2017.
224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.

Based on AlphaMark Advisors's 13F filing for Q1 2024, filed 18 Apr 2024.